+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diagnostic Specialty Enzymes - Global Strategic Business Report

  • PDF Icon

    Report

  • 182 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309901
The global market for Diagnostic Specialty Enzymes was estimated at US$1.1 Billion in 2023 and is projected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Diagnostic Specialty Enzymes Market - Key Trends & Drivers Summarized

Why Are Diagnostic Specialty Enzymes Essential in Modern Diagnostics?

Diagnostic specialty enzymes are crucial components in the development of diagnostic assays, playing a fundamental role in the detection of various diseases and conditions. These enzymes are used in clinical chemistry, molecular diagnostics, and immunoassays to catalyze specific reactions that help identify biomarkers for diseases such as diabetes, cardiovascular conditions, and infectious diseases.

The precision and efficiency of specialty enzymes make them indispensable in diagnostics, enabling healthcare professionals to deliver accurate and timely results. As the demand for point-of-care testing (POCT) and home diagnostic kits grows, the use of specialty enzymes is expanding, providing the essential biochemical tools needed to meet the rising need for quick and accurate testing solutions.

How Are Technological Advancements Influencing the Diagnostic Enzymes Market?

The diagnostic specialty enzymes market is witnessing significant growth due to technological advancements in enzyme engineering and production methods. Genetic engineering and recombinant DNA technology are enhancing the stability, specificity, and activity of these enzymes, making them more effective in diagnostic applications. Additionally, innovations in microfluidics and lab-on-a-chip technologies are integrating enzymes into compact diagnostic devices, enabling faster and more accurate testing in clinical and point-of-care settings.

The development of enzyme-linked immunosorbent assays (ELISAs) and other enzyme-based diagnostic platforms is also evolving, allowing for high-throughput and multiplex testing that can simultaneously detect multiple biomarkers. These advancements are increasing the efficiency and versatility of diagnostic specialty enzymes, broadening their application in modern diagnostics.

How Are Market Demands and Healthcare Trends Shaping the Enzymes Market?

The rising demand for early diagnosis and preventive healthcare is significantly influencing the diagnostic specialty enzymes market. As healthcare systems worldwide shift towards preventive care, there is a growing emphasis on the development of diagnostic tools that can detect diseases at early stages. Enzymes play a critical role in the creation of these tools, particularly in the detection of metabolic disorders, infections, and genetic conditions. The increasing incidence of chronic diseases like diabetes and cardiovascular conditions is driving demand for enzyme-based diagnostic tests that offer quick and reliable results.

Additionally, the growth of home-based testing and self-monitoring devices, such as glucose monitors and rapid antigen tests, is expanding the use of diagnostic specialty enzymes beyond traditional laboratory settings. The trend towards personalized medicine and tailored treatments is also influencing the market, as these enzymes facilitate precise and targeted diagnostic assays that support individualized healthcare.

What Factors Are Driving Growth in the Diagnostic Specialty Enzymes Market?

The growth in the diagnostic specialty enzymes market is driven by several factors, including technological advancements in enzyme engineering, the rising prevalence of chronic and infectious diseases, and the increasing demand for rapid diagnostic testing solutions. The shift towards preventive and personalized healthcare is encouraging the development of enzyme-based diagnostic tools that provide quick, accurate, and portable solutions.

The expansion of point-of-care testing (POCT) and home-based diagnostic kits, particularly in the wake of the COVID-19 pandemic, is further driving demand for specialty enzymes that are tailored for these applications. Additionally, the growing emphasis on developing sensitive and specific diagnostic assays for diseases like cancer, diabetes, and cardiovascular conditions is propelling investment in enzyme technology. The push for accessible healthcare solutions in emerging markets, supported by government initiatives and healthcare reforms, is also contributing to the expansion of the diagnostic specialty enzymes market globally.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Polymerases & Nucleases segment, which is expected to reach US$726.2 Million by 2030 with a CAGR of a 7.0%. The Proteases segment is also set to grow at 6.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $305.1 Million in 2023, and China, forecasted to grow at an impressive 5.7% CAGR to reach $266.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Diagnostic Specialty Enzymes Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Diagnostic Specialty Enzymes Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Diagnostic Specialty Enzymes Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Diagnostic Specialty Enzymes Market such as Advanced Enzymes Technologies Ltd., Affymetrix, Inc., Amano Enzymes Inc., American Laboratories, Inc., Amicogen, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 14 companies featured in this Global Diagnostic Specialty Enzymes market report include:

  • Advanced Enzymes Technologies Ltd.
  • Affymetrix, Inc.
  • Amano Enzymes Inc.
  • American Laboratories, Inc.
  • Amicogen, Inc.
  • BASF
  • BBI Solutions
  • Biocatalysts Ltd.
  • Codexis, Inc.
  • Dyadic International
  • F. Hoffmann-La Roche Ltd.
  • Life technologies
  • Micogen, Inc.
  • Nagase & Co. Ltd.
  • Novozymes A/S
  • Roche Holding Ag
  • Thermo Fisher Scientific, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Diagnostic Specialty Enzymes - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Early Diagnosis and Preventive Healthcare
  • Growth in Point-of-Care and Rapid Testing Solutions Boosting Enzyme Use
  • Increasing Adoption of Specialty Enzymes in Molecular Diagnostics
  • Technological Advancements in Enzyme Engineering for Enhanced Sensitivity
  • Surge in Use of Enzymes for Cancer and Genetic Disorder Detection
  • Development of Multiplex Diagnostic Assays Incorporating Specialty Enzymes
  • Growth in Home-Based and Self-Monitoring Diagnostic Kits
  • Expansion of Diagnostic Services in Emerging Markets Supporting Enzyme Demand
  • Rising Focus on Personalized Medicine and Targeted Diagnostics
  • Increasing Collaboration Between Diagnostic Companies and Enzyme Providers
  • Growth in Use of Enzymes for Monitoring Infectious Diseases
  • Advancements in Microfluidics and Lab-on-a-Chip Technologies Using Enzymes
  • Rising Investment in R&D for Enzyme Optimization and Stability
  • Expansion of Enzyme Applications in Veterinary Diagnostics
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Diagnostic Specialty Enzymes Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Polymerases & Nucleases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Oxidases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 32: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: USA Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: USA 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 35: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: USA Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: USA 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
CANADA
  • Table 38: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Canada 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Canada 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
JAPAN
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 44: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Japan 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 47: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Japan 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
CHINA
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 50: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: China Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: China 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 53: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: China Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: China 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
EUROPE
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 56: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
FRANCE
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 65: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: France Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: France 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 68: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: France Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: France 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
GERMANY
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 71: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Germany 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 74: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Germany Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: Germany 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
ITALY
  • Table 77: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Italy 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 80: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Italy Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: Italy 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 83: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: UK Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: UK 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 86: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: UK Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: UK 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 101: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 102: Rest of World Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 103: Rest of World 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
  • Table 104: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 105: Rest of World Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 106: Rest of World 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

Some of the 14 companies featured in this Global Diagnostic Specialty Enzymes market report include:
  • Advanced Enzymes Technologies Ltd.
  • Affymetrix, Inc.
  • Amano Enzymes Inc.
  • American Laboratories, Inc.
  • Amicogen, Inc.
  • BASF
  • BBI Solutions
  • Biocatalysts Ltd.
  • Codexis, Inc.
  • Dyadic International
  • F. Hoffmann-La Roche Ltd.
  • Life technologies
  • Micogen, Inc.
  • Nagase & Co. Ltd.
  • Novozymes A/S
  • Roche Holding Ag
  • Thermo Fisher Scientific, Inc.

Table Information